介入治疗对原发性肝癌中晚期患者肝功能的影响观察

在线阅读 下载PDF 导出详情
摘要   【摘 要】目的:分析原发性肝癌中晚期患者应用介入治疗对肝功能的影响。方法:我院 2017年 7月至 2019年 7月接收原发性肝癌中晚期患者 82例。采用随机分组原理分为对照组与观察组,两组均 41例。对照组采取常规方法治疗,观察组则应用介入方法治疗。对比分析临床效率与肝功能情况。结果:观察组与对照组治疗有效率分别为 92.7%与 82.9%,统计分析 P<0.05,符合统计学意义 ;相比较治疗前,治疗后两组患者 ALT、 ALB与 TBIL均改善,且观察组患者改善要显著优于对照组,符合统计学意义( P<0.05)。结论:与临床常规方法相比较,介入治疗原发性肝癌中晚期患者可提高临床效率,改善患者肝功能,应用价值较高。    【关键词】介入治疗 ;原发性肝癌 ;肝功能    [Abstract] Objective: to analyze the effect of interventional therapy on liver function in patients with advanced primary liver cancer. Methods: from July 2017 to July 2019, our hospital received 82 patients with advanced primary liver cancer. According to the principle of random grouping, 41 cases were divided into control group and observation group. The control group was treated with conventional methods, while the observation group was treated with interventional methods. Comparative analysis of clinical efficiency and liver function. Results: the effective rate of treatment in the observation group and the control group was 92.7% and 82.9% respectively, statistical analysis P < 0.05, consistent with statistical significance; before treatment, the alt, ALB and TBIL in the two groups were improved, and the improvement in the observation group was significantly better than that in the control group, consistent with statistical significance (P < 0.05). Conclusion: compared with the routine clinical methods, interventional therapy can improve the clinical efficiency and liver function of patients with primary liver cancer.
出处 《中华医学信息导报》 2020年2期
关键词
出版日期 2020年04月20日(中国期刊网平台首次上网日期,不代表论文的发表时间)